These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

769 related items for PubMed ID: 10728802

  • 1. Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem.
    Arroyo V, Jiménez W.
    J Hepatol; 2000; 32(1 Suppl):157-70. PubMed ID: 10728802
    [Abstract] [Full Text] [Related]

  • 2. Management of ascites and hepatorenal syndrome.
    Piano S, Tonon M, Angeli P.
    Hepatol Int; 2018 Feb; 12(Suppl 1):122-134. PubMed ID: 28836115
    [Abstract] [Full Text] [Related]

  • 3. Fluid retention in cirrhosis: pathophysiology and management.
    Kashani A, Landaverde C, Medici V, Rossaro L.
    QJM; 2008 Feb; 101(2):71-85. PubMed ID: 18184668
    [Abstract] [Full Text] [Related]

  • 4. [Treatment of ascites, hyponatremia and hepatorenal syndrome in liver cirrhosis].
    Ackermann D.
    Ther Umsch; 2009 Nov; 66(11):747-51. PubMed ID: 19885792
    [Abstract] [Full Text] [Related]

  • 5. Clinical Implications, Evaluation, and Management of Hyponatremia in Cirrhosis.
    Praharaj DL, Anand AC.
    J Clin Exp Hepatol; 2022 Nov; 12(2):575-594. PubMed ID: 35535075
    [Abstract] [Full Text] [Related]

  • 6. Pathogenetic factors and clinical elements in ascites and hepatorenal syndrome during liver cirrhosis.
    Gentilini P, Laffi G, La Villa G, Raggi VC.
    Ann Ital Med Int; 1999 Nov; 14(4):264-84. PubMed ID: 10638019
    [Abstract] [Full Text] [Related]

  • 7. Pathophysiology, diagnosis and clinical management of hepatorenal syndrome: from classic to new drugs.
    Barbano B, Sardo L, Gigante A, Gasperini ML, Liberatori M, Giraldi GD, Lacanna A, Amoroso A, Cianci R.
    Curr Vasc Pharmacol; 2014 Jan; 12(1):125-35. PubMed ID: 24678726
    [Abstract] [Full Text] [Related]

  • 8. Ascites and hepatorenal syndrome: pathogenesis and treatment strategies.
    Ginès P, Arroyo V, Rodés J.
    Adv Intern Med; 1998 Jan; 43():99-142. PubMed ID: 9506180
    [No Abstract] [Full Text] [Related]

  • 9. LEFT ventricular function assessed by echocardiography in cirrhosis: relationship to systemic hemodynamics and renal dysfunction.
    Nazar A, Guevara M, Sitges M, Terra C, Solà E, Guigou C, Arroyo V, Ginès P.
    J Hepatol; 2013 Jan; 58(1):51-7. PubMed ID: 22989573
    [Abstract] [Full Text] [Related]

  • 10. Hyponatremia in cirrhosis: pathophysiology and management.
    John S, Thuluvath PJ.
    World J Gastroenterol; 2015 Mar 21; 21(11):3197-205. PubMed ID: 25805925
    [Abstract] [Full Text] [Related]

  • 11. Update on peripheral arterial vasodilation, ascites and hepatorenal syndrome in cirrhosis.
    Knotek M, Rogachev B, Schrier RW.
    Can J Gastroenterol; 2000 Nov 21; 14 Suppl D():112D-121D. PubMed ID: 11110623
    [Abstract] [Full Text] [Related]

  • 12. Hyponatremia in Cirrhosis: An Update.
    Alukal JJ, John S, Thuluvath PJ.
    Am J Gastroenterol; 2020 Nov 21; 115(11):1775-1785. PubMed ID: 33156095
    [Abstract] [Full Text] [Related]

  • 13. Management of ascites in patients with liver cirrhosis: recent evidence and controversies.
    Hsu SJ, Huang HC.
    J Chin Med Assoc; 2013 Mar 21; 76(3):123-30. PubMed ID: 23497963
    [Abstract] [Full Text] [Related]

  • 14. Pathophysiology of Hepatorenal Syndrome.
    Velez JCQ, Latt N, Rodby RA.
    Adv Kidney Dis Health; 2024 Mar 21; 31(2):87-99. PubMed ID: 38649221
    [Abstract] [Full Text] [Related]

  • 15. Challenges and Management of Liver Cirrhosis: Pathophysiology of Renal Dysfunction in Cirrhosis.
    Solà E, Ginès P.
    Dig Dis; 2015 Mar 21; 33(4):534-8. PubMed ID: 26159270
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Chinese guidelines on the management of ascites and its related complications in cirrhosis.
    Chinese Society of Hepatology, Chinese Medical Association, Xu X, Duan Z, Ding H, Li W, Jia J, Wei L, Linghu E, Zhuang H.
    Hepatol Int; 2019 Jan 21; 13(1):1-21. PubMed ID: 30656520
    [Abstract] [Full Text] [Related]

  • 19. Review article: pathogenesis and pathophysiology of hepatorenal syndrome--is there scope for prevention?
    Møller S, Henriksen JH.
    Aliment Pharmacol Ther; 2004 Sep 21; 20 Suppl 3():31-41; discussion 42-3. PubMed ID: 15335398
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.